sodium salicylate has been researched along with 2,3-dihydroxybenzoic acid in 8 studies
*2,3-dihydroxybenzoic acid: RN given refers to parent cpd [MeSH]
*2,3-dihydroxybenzoic acid: RN given refers to parent cpd [MeSH]
| Studies (sodium salicylate) | Trials (sodium salicylate) | Recent Studies (post-2010) (sodium salicylate) | Studies (2,3-dihydroxybenzoic acid) | Trials (2,3-dihydroxybenzoic acid) | Recent Studies (post-2010) (2,3-dihydroxybenzoic acid) |
|---|---|---|---|---|---|
| 2,031 | 50 | 171 | 437 | 4 | 77 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berenshtein, E; Berman, ER; Chevion, M; Kitrossky, N; Ophir, A; Photiou, S; Rothman, Z | 1 |
| Obata, T; Yamanaka, Y | 2 |
| Aomine, M; Obata, T; Yamanaka, Y | 1 |
| Blandini, F; Desideri, S; Godi, L; Mancini, F; Martignoni, E; Nappi, G; Pacchetti, C | 1 |
| Ahlers, ST; Auker, CR; Axley, MJ; Elayan, IM; Prasad, PV | 1 |
| Mohanakumar, KP; Muralikrishnan, D; Thomas, B | 1 |
| Banerjee, R; Mohanakumar, KP; Sairam, K; Saravanan, KS | 1 |
1 trial(s) available for sodium salicylate and 2,3-dihydroxybenzoic acid
| Article | Year |
|---|---|
Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA.
Topics: Antiparkinson Agents; Biomarkers; Blood Platelets; Dopamine; Female; Gentisates; Humans; Hydroxybenzoates; Hydroxyl Radical; In Vitro Techniques; Levodopa; Linear Models; Male; Middle Aged; Oxidative Stress; Parkinson Disease; Sodium Salicylate; Superoxide Dismutase; Tyrosine | 1999 |
7 other study(ies) available for sodium salicylate and 2,3-dihydroxybenzoic acid
| Article | Year |
|---|---|
Hydroxyl radical generation in the cat retina during reperfusion following ischemia.
Topics: Animals; Cats; Eye Proteins; Free Radicals; Gentisates; Hydroxybenzoates; Reactive Oxygen Species; Reperfusion Injury; Retina; Sodium Salicylate; Time Factors | 1993 |
Glibenclamide, an antagonist of ATP sensitive K+ channels, blocks free radical generation in the rat myocardium.
Topics: Allopurinol; Animals; Enzyme Inhibitors; Free Radicals; Gentisates; Glyburide; Heart; Hydroxybenzoates; Male; Microdialysis; Myocardium; Perfusion; Potassium Channel Blockers; Potassium Channels; Potassium Chloride; Rats; Rats, Wistar; Sodium Salicylate; Sucrose | 1998 |
Protective effect of histidine on hydroxyl radical generation induced by potassium-depolarization in rat myocardium.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Histidine; Hydroxybenzoates; Hydroxyl Radical; Male; Microdialysis; Myocardial Reperfusion Injury; Myocardium; Potassium; Potassium Chloride; Rats; Rats, Wistar; Sodium Salicylate | 1999 |
Effect of hyperbaric oxygen treatment on nitric oxide and oxygen free radicals in rat brain.
Topics: Animals; Brain; Brain Chemistry; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Free Radicals; Hydroxides; Hydroxybenzoates; Hyperbaric Oxygenation; Male; Microdialysis; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitrites; Oxygen; Partial Pressure; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sodium Salicylate | 2000 |
Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Catalepsy; Cyclooxygenase Inhibitors; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Free Radical Scavengers; Gentisates; Glutathione; Homovanillic Acid; Hydroxybenzoates; Hydroxyl Radical; Male; Mice; Mice, Inbred BALB C; Monoamine Oxidase; MPTP Poisoning; Neostriatum; Neuroprotective Agents; Sodium Salicylate; Substantia Nigra | 2000 |
Iron (III) attenuates hydroxyl radical generation accompanying non-enzymatic oxidation of noradrenaline in the rat heart.
Topics: Animals; Female; Ferric Compounds; Hydroxybenzoates; Hydroxyl Radical; Intracellular Fluid; Male; Microdialysis; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Norepinephrine; Oxidation-Reduction; Rats; Rats, Wistar; Sodium Salicylate; Tyramine | 2002 |
Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Corpus Striatum; Diclofenac; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Gentisates; Hydroxybenzoates; Hydroxyl Radical; In Vitro Techniques; Male; Mortality; Neurodegenerative Diseases; Neuroprotective Agents; Pyrazoles; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Sodium Salicylate; Sulfonamides | 2003 |